Brief: Telcon Rf Pharmaceuticals Inc Reports 8.7% Passive Stake In Emmaus Life Sciences Inc As Of July 17
Aug 26 (Reuters) -
* TELCON RF PHARMACEUTICALS INC REPORTS 8.7% PASSIVE STAKE
IN
EMMAUS LIFE SCIENCES INC AS OF JULY 17 - SEC FILING
Source text - (http://bit.ly/2NyI7Je)
Further company coverage: EMMA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Emmaus Life Sciences
See all newsEmmaus Life Sciences Q2 revenue soars on licensing deal
Emmaus Life Sciences Q1 revenue falls driven by lower sales in U.S.
Brief: Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech
Emmaus Life Sciences Q3 revenue falls 38%, swings to loss
Brief: Emmaus Life Sciences CFO Yasushi Nagasaki Resigns